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Recent studies suggest that beta-adrenergic blocking agents
show promise in the management of cardionlyopathtes;
however, their role in acute myocarditis Is unknown. Cue
hundred 3 weak old into were infected with eoxsackievirus
133 and were given either metoprolol (n = 50) or normal
saline solution (n = 50) intraperitooeafly for 10 days .
Twenty mice from each group were observed for mortality
for 30 days . Of the remaining 60 mice, 10 from each group
were killed on day 3, 6 or 10 and examined for heart viral
titers and pathologic changes .
Mortality rate in the meloprolol group was 60% cum .
pared with 0% i, the saline group (p < 0.00.5). Viral titers
in day 10 of infection were
102b s
: 0.2
median tissue culture
Viral cardiomyopathy is a disease caused by multiplication
of virus in the myocardium, pericardium or endocardium
that temporarily or permanently affects the normal anatomy
and physiologic functions of the heart (1) . The overall
prevalence of myocarditis in patients with suspected viral
illness ranges from 2.3 to S% (2). In the acute phase of viral
myocarditis, patients may suffer from congestive heart fail-
ure and valvular insufficiency, whereas in the chronic phase
they may develop chronic heart failure, constrictive pericar-
ditis or valvular insufficiency (3).
Several drugs have been investigated in experimentally
induced coxsackievirus murine myocarditis to explore their
therapeutic potential in modulating the course of the disease .
Trials with corlicosteroids (4),
ibuprofen (5), sodium sa! y-
late and indomethacin (6) either did not alter the disease or
even had deleterious effects . Traditionally, beta-adrenergic
blocking agents have been considered to be contraindicated
in patients with congestive heart failure ; however, recent
studies have suggested that these agents improve survival
rates in patients with cardiomyopathy (7) and that their
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infective dose for the metoprolat group versus 102
.1 x
"'for
the ailing group (p < 0 .05) . Whereas pathollogie changes at
days 3,6 and 10 of infection were similar in both groups, on
day 30 of infection, inflammation, necrosis and mineraliza-
tion scores (mean cc HEM) were 1 .1 cc 0.3, 2 .1 ± 0,4, 2 .2 x
0.5 roc the metoprolal group versus 0.3 ± 1 .1, 0 .4 ± 0 .3,
0.4 ± 0 .3 for the saline group, respectively (p < 0.01). Six
noninfecled mice received metoprolol Intraperitoueally for
10 days ; there was no mortality during 30 days of ohseeva-
tion. In conclusion, metoprolol administration exerts dele-
terious effects i1 acute cossackievirus 113 marine myocar-
ditts.
(J Am Call Cordial 1988;12 .-412-4)
withdrawal resells in clinical deterioration 18). Moreover,
exercise was found to exert a deleterious effect on the course
of viral myocarditis in a marine model (9). We hypothesized
that beta-receptor blockade might exert a beneficial effect on
vim] myocarditis by placing the heart at rest . Furthermore, a
beta-blocker is occasionally used in the course of viral
myocarditis to control arrhythmias, palpitation or incidental
hypertension, however, its role in viral myocarditis has not
been previously investigated . Therefore, we sought to deter-
mine the effect of metoprolol on acute coxsackievirus B3
myocarditis in mice
.
Methods
Virus. Coxsackievirus B3 (nancy strain) was used to
produce the experimental infection after its passage in tissue
cultures, as has been described previously (10). Each mouse
was injected intraperitoneally with 0.1 ml of minimal essen-
tial medium of stock virus containing 10 1,2 median tissue
culture infective dose
.
Drug administration . Metoprolol(CIBA-CeigyCorp .)so-
lution was prepared by dissolving the powder in sterile water
for injection . The solution was sterilized with a 4 .5µm filter,
and each mouse was injected with 0 .013 mglg intraperilone-
ally at 7 :00 AM and 5 :00 PM, and 0.0065 mg/g at 12 noon,
daily for 10 days starting on day 0 of the study . The dose was
9735-Ia97Ioa'3 .na
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Table 1 . Study Groups
Study of acute phase of myocarditis
Group 1: infected, receiving metoprolol (n = 30)
Group II: infected, receiving saline solution (a = 30)
Mortality study
Group III : infected, receiving me(oprolol In = 20)
Group IV : infected, receiving saline solution (n =20)
Toxicity study
NonuJeetzd . ,eceiving
--lot
61
Control group
Noninfected, nontreated (n = 2)
decided on through a series of pilot studies in 3 week old
noninfected mice to achieve a reduction in heart rate of 40 to
50% throughout most of the day .
Experimental design (Table 1) . A total of 108 3 week old
cesarean-derived-l (CDI) Swiss Webster mice (Charles
River laboratory) was utilized in the study . Two noninfec-
led, nontreated mice were kept in a separate cage and served
as a control for the study groups .
Group! consisted of 30 mice infected with coxsackievirns
83 on day 0 of the study ; they received metoprolol for 10
days starting at day 0 . Group 11 consisted of 30 mice infected
with coxsackievirus B3 on day 0 of the study ; they received
saline solution for 10 days starting on day 0. Ten mice from
each group were killed on day 3, 6 or 10 . Groups I and 11
served to study the effect of metoprolol on the acute phase of
myocarditis . Group III consisted of 20 mice infected with
cossackievirut that received metoprolol for 10 days starting
on day 0 of the study, and Group IV consisted of 20 mice
infected with coxsackievirus that received saline solution for
10 days starting on day 0 of the study . Groups 111 and IV
were observed for mortality for 30 days . Six noninfected
mice were entered into a toxicity study .
Autopsy protocol. On the day they were killed, the mice
were anesthetized by ether and exsanguinated by way of the
axillary artery . Death assurance was performed by cervical
dislocation and the thoracic cavity was explored ; the heart
was excised and examined for gross pathologic changes . The
apex of the heart was cut and minced with a tissue grinder in
0.5 ml minimal essential media, and viral assay was per-
formed as described previously (11) .
The heart tuns then fixed in 10 formalin solution and
Table 3. Histopathologic Scores
ep
a 0.01 . 1 = inflammation; M = mincdization; N = --is.
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Table 2 . Viral Titers
Dey3
	
to•' -°^
Day 6 t0+-
Day 10 10`
1- 2
NS = not significant .
processedforhistologic exatninatien . Transverse sections at
the mid-left ventricular cavity level were obtained, and
histologic seriions were stained with hematoxylin-eosin.
Each section was examined for evidence of mononuclear
and polymorphonusdear cellular infiltration, necrosis and
mineralization, and was given a histologic score between 0
(no involvement noted) to 4+ (100% involvement), with I +,
2+ and 3+ representing 25, 50 and 75% involvement of the
histologic section, respectively. A similar semiquantitative
scoring system was utilized previously to assess the extent
of myocarditis (6) . Histologic examination was done without
the knowledge of the treatment given .
Toxicity study . A group of six 3 week old noninfected
mice was injected with metoprolol in the same dose utilized
in the study and was observed for 30 days for weight gain
and mortality .
Statistical analysis . Statistical analysis was done by the
Mann-Whitney test for the viral titers, Mantel-Haenszel test
for the comparison of survival of curves and Student's t test
for degree of histopathologic involvement . Data are ex-
pressed as mean ± SEM.
Results
Viral titers during the acute phase of myocarditis (Table 2).
On days 3 and 6 of infection, viral titers were similar in the
infected control group and infected metoprolol group ; how-
ever, on day 10 of infection, the viral titer was 102
.6 C 0.2
in
the metoprolol group versus 102
.1 0.1
in the control group (p
< 0.05) .
Histopathologic examination (Table 3), Heart sections re-
vealed focal myocardial involvement with mononuclear and
polymorphonuclear cellular infiltrates, necrosis and areas of
dystrophic mineralization. Histopathologic scores for days
Group 1 : Group 11
:
Metoprolol Saline pvadue'
413
NS
NS
coos
Day
Group b Meteprlrl Group II : NoIsed Saline
1 N M 1 N M
3 D .2 x0 .1 0.1'_3 .1 0.1'_0.1 0 0 0
6 2 .7x0 .2 2.5±04 1 .9x0.2 2.8x0.2 2 .2x0.4 1 .9!0.3
10 2 .9x0 .4 2.3*_0 .4 2A x0,3 2.7 x 0.2 1 .9 3 0.4 1 .9 x 0.4
30 1 .1e0 .3 2.1x0 .4 22x0.5 0.300.1' 0.4_0.3' 0 .4x0.5'
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Figure 1 . Mortally study : the two line ', represent the number of
surviving mice in the metoprolol (Group III) and saline (Group IV)
groups (•p < 0.005) .
3, 6 and 10 of infection were similar in both treated (Group 1)
and untreated (Group II) groups ; however, on day 30 of
infection, inflammation, necrosis and mineralization scores
were 1 . 1 ± 0 .3, 2
.1 ± 0
.4 and 2 .2 ± 0 .5
for the metoprolol
group (Group 111) versus 0.3 ± 0 .1 (p < 0.011, 0.4 ± 0 .3 (p <
0 .01) and 0 .4 ± 0.3 (p < 0.01) for the control group (Group
IV), respectively
.
Mortality study (Fig. 1) . In the metoprolol-treated group .
8 (40%) of the 20 mice in Group Ill survived, whereas in the
saline group (Group IV), all 20 mice (1007) survived (p <
0 .005) . Half of the dead mice exhibited aulolysis at the time
of death and autopsy was not perfe. med . In the remaining
dead mice, autopsy revealed the heart to be grossly involved
with exudates typical of myocarditis .
Toxicity study. Six mice that were not infected but re-
ceived mctoprolol continued to thrive normally ; the average
weight increased from 18 to 20 g at the beginning of t he study
to 26 to 30 g I week later (average weight gain about 50%)
.
There were no deaths in [his group or in the two control
noninfccted
. nonlreaed mice during 30 days of observation.
Discussion
Deleterious effect of beta-blockade therapy . Chronically
increased sympathetic tone contributes to increased arterial
vascular resistance and hearl rate . Such an increase in
afterload and heart rate may contrihu,e to hemndynamic
deterioration in the tailing heart and, in fact, sonic prelimi-
nary data (7) appear to favor the use of beta-blocking agents
in the management of patients with congestive heat failure .
The effect of b eta-blockers. however. i n acute myocurclitis is
not known . This study :bows that metoprolol, in a dose
sufficient to produce a beta-receptor blockade effect on
normal mice without any evidence of I oticity, is deleterious
to mice infected with coxsackievirus B3 . Infected, treated
mice had significantly greater mortality in the first 311 days
after infection, and the increased number of deaths was
JACC Vol . 12 . No . 2
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associated with mote viral replication on day 10 of infection
and more myocardial necrosis on day 30 of infection as
detected by histopathoiogic studies .
Mechanism. The mechanism of the metoprolol effect in
our study is not known
; however, it is possible that it either
interfered with body defense against viral replication or
unfavorably changed the hemodynamics of the infected heart .
It is possible that metoprolol did interfere with the natural
defense lines against infection, thus making the mice more
susceptible to infection . It was demonstrated that propranolol
(another beta-blocker) can inhibit the phagocylic activity of
polymorphonuclear leukocytes and monocyles (12), and may
suppress mitogenic activation of lymphocytes 113); however,
the effect of the drug on lymphocytes and interferon produc-
tion in our model was not investigated .
Conclusions . Metoprolol administration in acute murine
myocarditis leads to significantly increased mortality, in-
creased viral replication on day 10 of infection and more
cardiac damage on day 30 of infection .
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